Hyundai Pharmaceutical현대약품

Predicted impact: Medium

Supplementary data for abortion pill approval due next month; approval outcome uncertain, company is small (about ₩214B value).

Predicted impact: Low

Stock tip list; Korea Circuit's strong profit outlook already covered in recent items.

Predicted impact: Low

Stock move on a US peer's Phase 3 hair-loss result; not the company's own filing.